Bioinspired Artificial Liver System with hiPSC‐Derived Hepatocytes for Acute Liver Failure Treatment
The DOI matches its Crossref record; 42 of the 45 references it cites were found in a registry or an index.
Abstract
Bioartificial liver (BAL) system has become a promising alternative to traditional liver transplantation in rescuing acute liver failure (ALF) patients. Herein, inspired by natural microstructure of hepatic lobules, a novel biomimetic bioartificial liver system (BBALS) is developed by integrating human induced pluripotent stem cell‐derived hepatocytes (hiPSC‐Heps) ‐laden microparticles and semipermeable microtubes into a microfluidic platform. As the working units are hepatic lobules‐like semipermeable microtubes surrounding with serum‐free suspension differentiated hiPSC‐Heps microcarriers, the BBALS is endowed with functional cell aggregates and effective circulation system. Thus, the BBALS possesses high cell viability, favorable function regeneration, and effective substances exchange. Based on these features, a 3D liver chip with multiple parallel BBALS units is created for filtering the plasma of ALF rabbits, which validates the research significance and application potential of the proposed BBALS. Moreover, the novel integrated BBALS is applied to treat ALF rabbits and shows great advantages in increasing survival, generating serum proteins, and decreasing inflammation. These properties point to the broad prospects of BBALS in treating related diseases and improving traditional clinical methods.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This platform captures the synergistic regulation of glucose metabolism and pharmacological responses across organs, offering a powerful paradigm for interrogating multi-organ pathophysiology [220, 221].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [221]
In the citing paper
“Microfluidic technology offers high controllability, enabling the batch production of uniform, structurally adjustable cell-loaded micro-particles, providing ideal scaffolding materials for constructing functional liver tissue units (Fig. 12B) [198].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [198]
In the citing paper
“Tao et al. interfaced hiPSC-derived hepatic and pancreatic islet organoids within a unified microfluidic framework, faithfully reconstructing the human liver-islet axis under both euglycaemic and type-2-diabetic conditions.”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [221]
Citations
Cites
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size
Loh, Q. L., & Choong, C. (2013) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2012.0437 · Cited by 2,668
Gelatin-Methacryloyl Hydrogels: Towards Biofabrication-Based Tissue Repair
Klotz, B. J., Gawlitta, D., Rosenberg, A. J. W. P., Malda, J., & Melchels, F. P. W. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.01.002 · Cited by 846
Acute-on-Chronic Liver Failure
Arroyo, V., Moreau, R., & Jalan, R. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1914900 · Cited by 650
Acute-on-chronic liver failure: an update
Hernaez, R., Solà, E., Moreau, R., & Ginès, P. (2017) · Gut · doi:10.1136/gutjnl-2016-312670 · Cited by 605
Global liver disease burdens and research trends: Analysis from a Chinese perspective
Xiao, J., Wang, F., Wong, N.-K., He, J., Zhang, R., Sun, R., Xu, Y., Liu, Y., Li, W., Koike, K., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.004 · Cited by 547
Self-citationDeng, J., Wei, W., Chen, Z., Lin, B., Zhao, W., Luo, Y., & Zhang, X. (2019) · Micromachines · doi:10.3390/mi10100676 · Cited by 229
Microfluidic organ-on-a-chip models of human liver tissue
Moradi, E., Jalili-Firoozinezhad, S., & Solati-Hashjin, M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.08.041 · Cited by 204
Ma, Q., Song, Y., Sun, W., Cao, J., Yuan, H., Wang, X., Sun, Y., & Shum, H. C. (2020) · Advanced Science · doi:10.1002/advs.201903359 · Cited by 169
Research works printed but not linked: 4
- Huang D., 2020, Adv. Funct. Mater., 30
- Bydlowski S. P., 1988, Braz. J. Med. Biol. Res., 21, 535
- Li G., 2020, Research, 2020, 2603048
- Nicolas C. T., 2016, Curr. Opin. Gastroenterol., 32, 189
Cited by
Developing tissue engineering strategies for liver regeneration
Wang, J., Huang, D., Yu, H., Cheng, Y., Ren, H., & Zhao, Y. (2022) · Engineered Regeneration · doi:10.1016/j.engreg.2022.02.003 · Cited by 80
Self-citationFunctional hydrogels for treatment of dental caries
Song, C., Liu, R., Kong, B., Gu, Z., & Chen, G. (2023) · Biomedical Technology · doi:10.1016/j.bmt.2023.05.002 · Cited by 50
Engineered stem cells by emerging biomedical stratagems
Wang, J., Zhang, X., Chen, H., Ren, H., Zhou, M., & Zhao, Y. (2024) · Science Bulletin · doi:10.1016/j.scib.2023.12.006 · Cited by 37
Self-citationReview: 3D cell models for organ-on-a-chip applications
Żuchowska, A., Baranowska, P., Flont, M., Brzózka, Z., & Jastrzębska, E. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342413 · Cited by 44
Liver spheroids on chips as emerging platforms for drug screening
Huang, D., Zhang, X., Fu, X., Zu, Y., Sun, W., & Zhao, Y. (2021) · Engineered Regeneration · doi:10.1016/j.engreg.2021.10.003 · Cited by 45
Self-citationHydrogel-Encapsulated Pancreatic Islet Cells as a Promising Strategy for Diabetic Cell Therapy
Huan, Z., Li, J., Luo, Z., Yu, Y., & Li, L. (2024) · Research · doi:10.34133/research.0403 · Cited by 47
He, J., Wang, J., Pang, Y., Yu, H., Qin, X., Su, K., Xu, T., & Ren, H. (2022) · International Journal of Bioprinting · doi:10.18063/ijb.v8i3.581 · Cited by 35
“hiPSC-Heps obtained using our optimized protocol showed excellent expression of liver-specific functions similar to PHHs, and they were successfully applied in bioartificial liver systems for acute liver failure treatment[26,27].”
MethodSelf-citationRecent advances in liver‐on‐chips: Design, fabrication, and applications
Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 44
Hydrogel-Based Strategies for Liver Tissue Engineering
Zhang, Y., Li, L., Dong, L., Cheng, Y., Huang, X., Xue, B., Jiang, C., Cao, Y., & Yang, J. (2024) · Chem & Bio Engineering · doi:10.1021/cbe.4c00079 · Cited by 39
Developing Liver Microphysiological Systems for Biomedical Applications
Wang, J., Wu, X., Zhao, J., Ren, H., & Zhao, Y. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302217 · Cited by 27
Self-citationRecent Advances in Functional Hydrogels for Treating Dental Hard Tissue and Endodontic Diseases
Li, H., Zhang, D., Bao, P., Li, Y., Liu, C., Meng, T., Wang, C., Wu, H., & Pan, K. (2024) · ACS Nano · doi:10.1021/acsnano.4c02754 · Cited by 28
Song, B., Wang, C., Fan, S., Zhang, L., Zhang, C., Xiong, W., Hu, Y., Chu, J., Wu, D. Q., & Li, J. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202305245 · Cited by 29
Bioartificial livers: a review of their design and manufacture
Tuerxun, K., He, J., Ibrahim, I., Yusupu, Z., Yasheng, A., Xu, Q., Tang, R., Aikebaier, A., Wu, Y., Tuerdi, M., et al. (2022) · Biofabrication · doi:10.1088/1758-5090/ac6e86 · Cited by 24
“In addition, Wang et al [58] developed a novel biom-emetic BAL system that incorporated microcarriers loaded with hiPSC-derived hepatocytes in a hollow fiber bioreactor, which produced a great outcome in the treatment of ALF rabbits.”
Wang, Z., Lin, X., Shi, Y., Yan, H., Shang, Y., & Ren, H. (2026) · Biomedical Technology · doi:10.1016/j.bmt.2025.100131 · Cited by 22
Self-citationIon‐Specific Hydrogel Microcarriers with Biomimetic Niches for Bioartifical Liver System
Lin, X., Li, J., Wang, J., Filppula, A. M., Zhang, H., & Zhao, Y. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402999 · Cited by 16
Self-citationEmerging Functional Porous Scaffolds for Liver Tissue Engineering
Wang, J., Huang, D., Chen, D., Ren, H., & Zhao, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403741 · Cited by 15
Self-citationEmerging approaches for the development of artificial islets
Li, J., Sun, L., Bian, F., Pandol, S. J., & Li, L. (2024) · Smart Medicine · doi:10.1002/smmd.20230042 · Cited by 14
Self-citationBiomimetic Vascularized iPSC‐Hepatocyte Spheroids for Liver Regeneration
Wang, J., Huang, D., Ren, H., & Zhao, Y. (2025) · Advanced Science · doi:10.1002/advs.202405662 · Cited by 13
Self-citationWang, J., Qin, X., Kong, B., & Ren, H. (2022) · Smart Medicine · doi:10.1002/smmd.20220002 · Cited by 13
Self-citationConstructing biomimetic microenvironments for liver regeneration
(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11
“This platform captures the synergistic regulation of glucose metabolism and pharmacological responses across organs, offering a powerful paradigm for interrogating multi-organ pathophysiology [220, 221].”
Self-citationEmerging nano/micro drug delivery system for hepatic ischemia-reperfusion injury
Fu, X., Yang, W., Ge, D., & Ren, H. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217357 · Cited by 13
Self-citationFeng, L., Wang, Y., Fu, Y., Yimamu, A., Guo, Z., Zhou, C., Li, S., Zhang, L., Qin, J., Liu, S., et al. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10552 · Cited by 13
Developing organs-on-chips for biomedicine
Zhu, Y., Cai, L., Chen, H., & Zhao, Y. (2022) · 中国科学通报:英文版 · doi:10.1016/j.scib.2022.04.012 · Cited by 12
Self-citationBioinspired Spatially Ordered Multicellular Lobules for Liver Regeneration
Wang, J., Huang, D., Ren, H., & Zhao, Y. (2025) · Research · doi:10.34133/research.0634 · Cited by 10
“Generally, the transplanted hepatocytes can partially restore liver functions, including protein synthesis, glycogen storage, and detoxification, facilitating rapid recovery [ 11 – 13 ].”
Self-citationBiomimetic cell encapsulations by microfluidics
Wang, J., Huang, D.-F., Fang, Y.-L., Ren, H.-Z., & Zhao, Y.-J. (2024) · Science China Materials · doi:10.1007/s40843-024-2903-0 · Cited by 11
“A new type of biomimetic bioartificial liver system (BBALS) has been developed to mimic the unit structure of liver lobules [42].”
Self-citationStem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development
Feng, L., Wang, Y., Fu, Y., Li, T., & He, G. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10672-5 · Cited by 9
“Studies have focused on developing strategies using multiple stem cell-type-derived hepatic-like cells (HLCs), including hepatic stem cells (HSCs), embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs) [9–11].”
Niu, X., Lin, M., & Lee, B. H. (2022) · Gels · doi:10.3390/gels8070404 · Cited by 10
“Moreover, microfluidic devices can offer round cell aggregates with an in vivo hepatocyte-like morphology and sustain liver-like cell functionality, but they cannot support long-term culture and are not suitable for high throughput applications [7,8,24,25].”
BackgroundBioartificial liver: Where lies the path ahead—A review
Jiang, Q., Su, Y., Cao, X., Zhang, H., Zhang, J., & Li, L. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000788 · Cited by 11
“12] A number of significant advances took place last year as Chinese teams conducted a series of genetically modified porcine liver transplantation surgeries.”
Biomimetic Gland Models with Engineered Stratagems
Lin, X., Sun, L., Lu, M., & Zhao, Y. (2023) · Research · doi:10.34133/research.0232 · Cited by 11
Self-citationYun, J., Jeon, T., & Kim, S. M. (2025) · Biomimetics · doi:10.3390/biomimetics10070443 · Cited by 10
“Experimental results obtained from plasma filtration studies using an ALF rabbit model highlighted the potential of this BBALS, establishing a valuable foundation for future developments in ALF therapeutics [62].”
Wang, J., Situ, P., Chen, S., Wu, H., Zhang, X., Liu, S., Wang, Y., Xie, J., Chen, H., & Duan, Y. (2022) · Cells · doi:10.3390/cells11244117 · Cited by 7
Self-citationPersonalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips
Buck, F., Bugter, J., Yorukoglu, G., Dastjerd, M. K., & Winkler, T. E. (2026) · Advanced Biology · doi:10.1002/adbi.202500536 · Cited by 10
“Cholangiocytes are additionally available from minimally invasive liquid (bile) biopsies [ 236, 237 ], as well as via hepatic progenitors or hepatocyte-to-biliary transdifferentia-tions [ 238 ].”
Microperfused Biomimetic Liver‐on‐a‐Chip for High‐Throughput Hepatotoxicity Screening
Zhao, J.-Q., Huang, D., Wang, J., & Zhao, Y. (2025) · Small · doi:10.1002/smll.202505653 · Cited by 5
Self-citationOrthotopic implantable liver decellularized scaffold for acute liver failure
Wang, J., Qin, X., Xia, S., Liu, S., & Ren, H. (2022) · Engineered Regeneration · doi:10.1016/j.engreg.2022.10.001 · Cited by 8
Self-citationFunctional hydrogels for dental disease treatment
Li, H., Xu, X., Zhang, D., Li, H., & Bao, P. (2025) · Soft Science · doi:10.20517/ss.2025.54 · Cited by 4
Engineering microfluidic human liver-islet crosstalk platform for recapitulating MASLD
Li, J., Wu, Z., Gan, J., Zhi, Y., Zhao, Y., & Li, L. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.165209 · Cited by 6
Self-citationThree-dimensional cell-based strategies for liver regeneration
Guo, D., XIA, X., & Yang, J. (2024) · Biocell · doi:10.32604/biocell.2024.051095 · Cited by 3
“This intervention not only mitigated in fl ammation, but also facilitated the production of serum proteins, ultimately leading to improved survival rates [119].”
Wani, S. I., Mir, T. A., Nakamura, M. M., Tsuchiya, T., Alzhrani, A., Iwanaga, S., Arai, K., Alshehri, E. A., Shamma, T., Obeid, D. A., et al. (2024) · Bioprinting · doi:10.1016/j.bprint.2024.e00355 · Cited by 3
Ye, Z., Yan, J., Wang, Y., Lin, Y., Wang, C., Yang, Q., Ji, T., Zhou, E., Zheng, Q., Zhong, D., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.12.024 · Cited by 8
“Further advancements involve integrating these cells into biomimetic microfluidic platforms that mimic the hepatic lobule, enhancing their viability and detoxification functions for treating liver failure in animal models [33].”
Zhong, Z., Liang, W., Dai, Y., Xue, C., Zhou, D., Xu, Z., Li, L., Pan, L., He, C., Zhou, X., et al. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70620 · Cited by 2
Weng, R., Wu, H., Xu, Y., Wang, Z., Gu, S., & Chen, K. (2026) · iScience · doi:10.1016/j.isci.2026.115154 · Cited by 2
“88”
C3A Cells-Inoculated Affinity Membrane for Bilirubin Removal
Shen, Y., Liu, H., Luo, H., Liu, X., Sun, Y., Ge, D., & Shi, W. (2022) · Coatings · doi:10.3390/coatings13010050 · Cited by 1
An Instant Update on Stem Cell Therapy
Hoh, Y. K. (2025) · The American Biology Teacher · doi:10.1525/abt.2025.87.1.6 · Cited by 1
Troev, I. P., Anatolievich, S. A., Golderova, A. S., Киселев, С. Л., Alekseev, V. A., Николаевич, Е. А., & Afanasyevich, V. A. (2024) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2024230578
Development of machine perfusion strategies for liver support and beyond
Fu, B., Wang, J., Yu, W., & Ren, H. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.03.019 · Cited by 2
Self-citationSSD: Targeting inflammasome and oxidative stress as a therapeutic strategy in inflammatory diseases
Zhao, Y., Fu, X., Zuo, H., Wang, X., Li, S., Wu, T., cheng, C., Xu, M., & Xu, G. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.130956
Self-citationRen, H., Ge, D., Li, Z., & Wang, J. (2026) · Advanced Functional Materials · doi:10.1002/adfm.76040
“Our group previously developed microcarriers with biomimetic niches for stem cell culture and bioartificial liver systems [30, 31].”
Self-citationXue, T., Zhang, J., Wang, B., Li, F., Chen, G., Xu, Y., Luo, Y., Sun, J., Lao, Y., Wang, J., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.05.025 · Cited by 1
Self-citationZhou, Y., Zeng, M., Fu, G., & Gao, Y. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11172-y
“[ 106, 107] These systems are being evaluated for multiple indications, including acute liver failure (ALF), acute-on-chronic liver failure (ACLF), and viral hepatitis-associated liver failure, as well as adjunctive therapies to enhance post-hepatectomy liver regeneration.”
Metadata
- Authors
- Wang, J., Ren, H., Liu, Y., Sun, L., Zhang, Z., Zhao, Y., & Shi, X.
- Affiliations
- Nanjing Drum Tower Hospital (CN)
- Corresponding author
- Zhao, Yuanjin
- Shi, Xiaolei
- Venue
- Advanced Healthcare Materials
- Publisher
- Wiley
- Published
- 2021-10-12
- Volume
- 10
- Issue
- 23
- Pages
- e2101580-e2101580
- ISSN
- 2192-2640 (ISSN-L)
- 2192-2659
- OpenAlex
- W3202017670
- Cited by
- 49
- References
- 45
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 13 · 2023: 7 · 2022: 9 · 2021: 1
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Healthcare Materials (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81872359, 81670566)
- Natural Science Foundation of Jiangsu Province (BK20190114)
- Nanjing Medical Science and Technique Development Foundation (QRX17129)
- Nanjing University
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- bioartificial liver, acute liver failure, microcarriers, microfluidic platform, plasma filtration, liver regeneration, inflammation reduction, rabbit model
- MeSH terms
- Animals, Humans, Liver, Rabbits, Liver Failure, Acute, Liver, Artificial, Hepatocytes, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.